CS logo
small CS logo
Royal Marsden Hospital - Chelsea, London

London, United Kingdom
Cancer treatment center in London, England
203 Fulham Rd., London SW3 6JJ

About Royal Marsden Hospital - Chelsea, London


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
7
Institute of Cancer Research, United Kingdom
4
Eli Lilly and Company
1
Incyte Corporation
1
Royal Marsden NHS Foundation Trust
1
United Therapeutics
1
University of Sydney
1
Total Rows: 7

Clinical Trials at Royal Marsden Hospital - Chelsea, London


During the past decade, Royal Marsden Hospital - Chelsea, London conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2211443300002200000000001111Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Modelling Internal Hepatic Movement With an External Abdominal Marker
2006-06-01
Unknown status
10
Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma
2012-01-01
2019-03-01
Completed
266
A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)
2012-05-01
2022-05-01
Unknown status
261
Phase III Radium 223 mCRPC-PEACE III
2015-10-01
2025-12-01
Active, not recruiting
446
SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
2015-05-22
2021-05-12
Completed
539
Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
2014-03-01
2025-12-01
Active, not recruiting
802
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
2016-12-23
2022-03-01
Completed
122
Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma
2018-02-04
2022-12-31
Active, not recruiting
37

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Royal Marsden Hospital - Chelsea, London" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials, followed by "Institute of Cancer Research, United Kingdom" with 4 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Royal Marsden NHS Foundation Trust" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Marsden Hospital - Chelsea, London" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "Astellas Pharma Europe Ltd." with 1 trials as a collaborator and "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEuropean Organisationfor Research andTreatment of Cancer -EORTC: 7European Organisationfor Research andTreatment of Cancer -EORTC: 7Institute of CancerResearch, UnitedKingdom: 4Institute of CancerResearch, UnitedKingdom: 4Eli Lilly and Company: 1Eli Lilly and Company: 1Incyte Corporation: 1Incyte Corporation: 1Royal Marsden NHSFoundation Trust: 1Royal Marsden NHSFoundation Trust: 1United Therapeutics: 1United Therapeutics: 1University of Sydney: 1University of Sydney: 1

Created with Highcharts 11.1.0Top CollaboratorsCancer Research UK: 2Cancer Research UK: 2Cancer Trials Ireland: 2Cancer Trials Ireland: 2ETOP IBCSG PartnersFoundation: 2ETOP IBCSG PartnersFoundation: 2Astellas Pharma Europe Ltd.: 1Astellas Pharma Europe Ltd.: 1Australian and NewZealand Urogenital andProstate Cancer TrialsGroup: 1Australian and NewZealand Urogenital andProstate Cancer TrialsGroup: 1Bayer: 1Bayer: 1Canadian UrologicOncology Group: 1Canadian UrologicOncology Group: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1European Organisationfor Research andTreatment of Cancer -EORTC: 1Latin AmericanCooperative OncologyGroup: 1Latin AmericanCooperative OncologyGroup: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1

Clinical Trials Conditions at Royal Marsden Hospital - Chelsea, London


According to Clinical.Site data, the most researched conditions in "Royal Marsden Hospital - Chelsea, London" are "Any Stage of Any Thymic Malignancy" (1 trials), "Any Stage of Lung Cancer (Any Histotype)" (1 trials), "Any Stage of Malignant Pleural Mesothelioma" (1 trials), "Breast Neoplasm Female" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Royal Marsden Hospital - Chelsea, London" in a lesser frequency.

Clinical Trials Intervention Types at Royal Marsden Hospital - Chelsea, London


Most popular intervention types in "Royal Marsden Hospital - Chelsea, London" are "Drug" (12 trials), "Radiation" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (2 trials), "Placebo" (2 trials), "3-dimensional conformal radiation therapy" (1 trials), "Abemaciclib" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Royal Marsden Hospital - Chelsea, London


The vast majority of trials in "Royal Marsden Hospital - Chelsea, London" are 12 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Royal Marsden Hospital - Chelsea, London


Currently, there are NaN active trials in "Royal Marsden Hospital - Chelsea, London". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Royal Marsden Hospital - Chelsea, London, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Royal Marsden Hospital - Chelsea, London, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 7Phase 2: 7Phase 3: 7Phase 3: 7Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 7Active, not recruiting: 7Completed: 5Completed: 5Unknown status: 3Unknown status: 3Terminated: 1Terminated: 1